Get started
Author

Yi Ba

Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study
2026 · Lin Shen, Xiaotian Zhang, et al. · The Lancet · 14
The evolving global landscape of first-in-class oncology drug innovation
2026 · Xiangyun Mao, Zhaoqing Wang, et al. · Signal Transduction and Targeted Therapy · 6
PDF
The histone demethylase KDM4A promotes esophageal cancer progression by epigenetically activating LRG1-mediated TGF-β signaling
2026 · Yueting Han, Huiya Wang, et al. · APOPTOSIS · 2
[68Ga]Ga-NY104 PET/CT and [18F]FDG PET/CT in patients with metastatic clear cell renal cell carcinoma (NYCRM): A prospective, single-center, single-arm, comparative imaging trial
2026 · Xinchun Yan, Xiaoyuan Li, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2
Advances in therapeutic approaches to gastric cancer
2026 · Feng Wang, Zi‐Xian Wang, et al. · CA A Cancer Journal for Clinicians · 1
PDF
Assessing Graded Histological Regression as Basis for Treatment Modification after Neoadjuvant Therapy in LAGC: An Exploratory Phase II Study
2026 · Dongfeng Song, Yajie Rong, et al. · Annals of Surgical Oncology · 1
Neoadjuvant/adjuvant serplulimab vs. placebo combined with chemotherapy for PD-L1–positive gastric cancer: A randomized, double-blind, multicenter phase 3 study.
2026 · Lin Shen, Xiaotian Zhang, et al. · Journal of Clinical Oncology · 1
CACA guidelines for managing cancer therapy-induced neutropenia (2026)
2026 · Li Xiao, Fenghua Wang, et al. · Holistic Integrative Oncology · 1
PDF
Treatment of metastatic pancreatic cancer with concurrent BRAF V600E mutation and germline BRCA2 mutation: a case report
2026 · Xiaoting Ma, Mei Guan, et al. · Chinese Clinical Oncology · 1
A phase 2 study of LBL-007 (anti-LAG-3) plus tislelizumab (anti-PD-1) and chemotherapy as first-line treatment in patients with unresectable locally advanced/metastatic esophageal squamous cell carcinoma.
2026 · Yi Ba, Jing Zhang, et al. · Journal of Clinical Oncology · 1
PDF
Methyltransferase-like 3/14-mediated m 6 A Silencing of GPx3 Drives Lipophagy Dysfunction and Ferroptosis Resistance in Colorectal Cancer
2026 · Huiya Wang, Yingying Jin, et al. · Research · 1
Anti-cancer drug clinical research
2026 · Fei Ma, Hongming Pan, et al. · Holistic Integrative Oncology
PDF
A Multinational, Retrospective, Real-World Study: Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Beyond First-line in East Asia (HER2+ GASTA Study)
2026 · Do-Youn Oh, Winnie Yeo, et al. · Cancer Research and Treatment
PDF
Single-Cell eQTL-Guided Mendelian Randomization Reveals a Dual-Axis Immune Evasion Mechanism and Therapeutic Targets in Esophageal Cancer
2026 · Yi Li, Ziqi Wan, et al. · Discovery Medicine
PDF
Inhibiting METTL3 synergizes with Notch blockade to treat ESCC by targeting cancer stemness via m6A-JAG2
2026 · Jingjing Duan, Yingying Jin, et al. · Journal of Gastroenterology
A phase II trial evaluating liposomal irinotecan combined with capecitabine as second-line therapy for biliary tract cancer.
2026 · Zhiyang Zhang, Mei Guan, et al. · Journal of Clinical Oncology
ATM mutations in pancreatic cancer: A real-world analysis of molecular landscapes, clinical heterogeneity, and prognostic impact.
2026 · Xiaoting Ma, Wenqi Han, et al. · Journal of Clinical Oncology
Distinct Germline Mutation Landscape and Clinical Implications in Chinese Colorectal Cancer: A Large‐Scale Genomic Analysis of 1094 Patients
2026 · Liting Lu, Xinyu Peng, et al. · Cancer Medicine
Synergistic antitumor effect between Olaparib and Chidamide by regulation of MYBL2 in lung cancer
2026 · Lila Zhu, Zhi Ji, et al. · Anti-Cancer Drugs
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma, with or without peritoneal metastases: a post-hoc analysis on RATIONALE-305 study
2026 · Miao-Zhen Qiu, Keun-Wook Lee, et al. · EClinicalMedicine
Integrated supportive care across the whole cancer journey: a new paradigm
2026 · Jun Zhang, Xianglin Yuan, et al. · Holistic Integrative Oncology
PDF
Current situation and unmet demands of supportive care for cancer patients in China
2026 · Mengyan Xie, Li Xiao, et al. · Holistic Integrative Oncology
PDF
Cellular Senescence in Gastric Cancer: Molecular Mechanisms, Microenvironment Remodeling and Therapeutic Implications
2026 · Zhiyuan Shi, Zhao Sun, et al. · Aging and Disease
PDF
Works count: 23
Citation count: 31
H-index: 2
I10-index: 1
Year
Topic
Type